<!DOCTYPE html>
<html>
<head>
	<title>Neulasta</title>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
	<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent" />
	<meta name="apple-mobile-web-app-capable" content="yes" />
	<meta name="viewport" content="width=device-width; initial-scale=1.0; maximum-scale=1.0;" />
	<link href="css/seg_tablet.css" rel="stylesheet" type="text/css" media="all" />
	<script type="text/javascript" src="js/lib/seg_tablet_include.js"></script>
</head>

<body>

<div id="navigation" class="i:navigation">
	<h4 class="index">Index</h4>
	<h4 class="references">References</h4>
	<h4 class="track">
		<span>Humanity</span>
		<span>Economy</span>
	</h4>
	<div class="progress"></div>
	<ul class="references">
		<li class="id:slide_7_a">Biosimilars</li>
		<li class="id:slide_moa">Why is Neulasta<sup>&reg;</sup> different?</li>
		<li class="id:slide_11_a">References</li>
	</ul>
</div>

<div id="sidebar"></div>

<div id="display">

	<div id="presentation" class="i:presentation">
	
		<div class="slide front">
			<h1>Frontpage</h1>
			<h2>Entrance</h2>
		</div>

		<div class="slide slide_e1 i:neulastaE1">
			<h1>Relative Dose Intensity</h1>
			<h2>Overview of benefits</h2>
			<div class="graph">
				<div class="extraA"></div>
				<div class="extraB"></div>
				<div class="extraC"></div>
			</div>

			<div class="sliderA"></div>
			<div class="sliderB"></div>
			<div class="tumor"></div>
		</div>

		<div class="slide slide_e2 i:neulastaE2">
			<h1>ANC</h1>
			<div class="slider"></div>
		</div>

		<div class="slide slide_e3 i:neulastaE3">
			<h1>Survival</h1>
			<div class="green_button"></div>
			<div class="yellow_button"></div>
			<div class="red_button"></div>
		</div>

		<div class="slide slide_e4 i:neulastaE4">
			<h1>Choose Perspective</h1>
			<h2>Choose Perspective</h2>
			<div class="economic">Economic</div>
			<div class="clinical">Clinical</div>
		</div>

		<div class="slide tracks slide_1AB">

			<div class="track track_a slide_1_a">
				<h1>Exploring the impact of FN for your hospital</h1>
				<h2>Your situation</h2>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>

			<div class="track track_b slide_1_b i:neulasta1B">
				<h1>Cost of Febrile Neutropenia</h1>
				<h2>Impact of FN</h2>
				<h3>The cost of an FN event</h3> 
				<div class="left_graph"></div>
				<div class="right_graph"></div>
				<div class="click_area">
					<div class="click_area_green"></div>
					<div class="click_area_orange"></div>
					<div class="click_area_red"></div>
					<div class="click_area_blue"></div>
				</div>
				<div class="move_on_button id:slide_1_b_2"></div>
				<div class="calc_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>

			<div class="subslide slide_1_b_2 i:neulastaClose">
				<h1>Cost of Febrile Neutropenia</h1>
				<h3>Mean duration of hospitalization due to febrile neutropenia (FN) (days)</h3>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>		

		</div>

		<div class="slide tracks slide_2AB">

			<div class="track track_a slide_2_a_1 i:neulasta2A1">
				<h1>Neulasta<sup>&reg;</sup> reduces Febrile<br />Neutropenia by more than 90%</h1>
				<h2>Reducing Febrile Neutropenia</h2>
				<h3>Neulasta<sup>&reg;</sup> significantly reduces febrile neutropenia</h3>
				<div class="matches">
					<div class="fire"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
				</div>
				<div class="match_texts">
					<div class="hospital"></div>
					<div class="hospital_prevent"></div>
				</div>
				<div class="move_on_button id:slide_2_a_1_2"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>
		
			<div class="subslide slide_2_a_1_2 i:neulasta2A12 i:neulastaClose">
				<h1>Neulasta<sup>&reg;</sup>  reduces Febrile<br />Neutropenia by more than 90%</h1>
				<h3>Neulasta<sup>&reg;</sup> significantly reduces febrile neutropenia</h3>
				<div class="move_on_button id:slide_2_a_1_3"></div>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>

			<div class="subslide slide_2_a_1_3 i:neulastaClose">
				<h1>Neulasta<sup>&reg;</sup>  reduces Febrile<br />Neutropenia by more than 90%</h1>
				<h3>Chemotherapy delivery is best supported by Neulasta<sup>&reg;</sup></h3>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>


			<div class="track track_b slide_2_b_1 i:neulasta2B1">
				<h1>Neulasta<sup>&reg;</sup> reduces Hospitalization<br />by more than 90%</h1>
				<h2>Reducing Hospitalization</h2>
				<h3>Neulasta<sup>&reg;</sup> primary prohylaxis vs. placebo</h3>
				<div class="matches">
					<div class="fire"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
					<div class="ice"></div>
				</div>
				<div class="match_texts">
					<div class="hospital"></div>
					<div class="protected"></div>
				</div>
				<div class="move_on_button id:slide_2_b_1_2"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div><strong></strong>
			</div>

			<div class="subslide slide_2_b_1_2 i:neulastaClose">
				<h1>Neulasta<sup>&reg;</sup>  reduces Hospitalization<br />by more than 90%</h1>
				<h3>Neulasta<sup>&reg;</sup> primary prohylaxis vs. placebo</h3>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>

		</div>

		<div class="slide tracks slide_3AB">

			<div class="track track_a slide_3_a_1 i:neulasta3A1">
				<h1>Neulasta<sup>&reg;</sup> reduces Febrile<br />Neutropenia by 83%</h1>
				<h2>Reduces FN by 83%</h2>
				<h3>Incidence of FN (all cycles)</h3>
				<div class="beds"></div>
				<div class="men"></div>
				<div class="move_on_button id:slide_3_a_1_2"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div><strong></strong>
			</div>

			<div class="subslide slide_3_a_1_2 i:neulasta3A12 i:neulastaClose">
				<h1>Neulasta<sup>&reg;</sup> reduces Febrile<br />Neutropenia by 83%</h1>
				<h3>Incidence of FN (all cycles)</h3>
				<div class="move_on_button id:slide_3_a_1_3"></div>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>
	
			<div class="subslide slide_3_a_1_3 i:neulastaClose">
				<h1>Neulasta<sup>&reg;</sup> reduces Febrile<br />Neutropenia by 83%</h1>
				<h3>Neulasta<sup>&reg;</sup> significantly reduces FN impact</h3>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>
		
		
			<div class="track track_b slide_3_b_1 i:neulasta3B1">
				<h1>Neulasta<sup>&reg;</sup> reduces FN and related costs<br />by 50% compared to daily G-CSF</h1>
				<h2>Reduces FN and related costs by 50%</h2>
				<h3>Neulasta<sup>&reg;</sup> halves hospitalization cause by to febrile neutropenia</h3>
				<div class="beds"></div>
				<div class="men"></div>
				<div class="move_on_button id:slide_3_b_1_2"></div>
				<div class="anti_button id:slide_3_b_1_3"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div><strong></strong>
			</div>
		
			<div class="subslide slide_3_b_1_2 i:neulastaClose">
				<h1>Neulasta<sup>&reg;</sup> reduces FN and related costs<br />by 50% compared to daily G-CSF</h1>
				<h3>Neulasta<sup>&reg;</sup> halves hospitalization cause by to febrile neutropenia</h3>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>
		
			<div class="subslide slide_3_b_1_3 i:neulasta3B13 i:neulastaClose">
				<h1>Neulasta<sup>&reg;</sup>  reduces FN and related costs by 50% compared to daily G-CSF</h1>
				<h3>Neulasta<sup>&reg;</sup> halves hospitalization cause by to febrile neutropenia</h3>
				<div class="pills"></div>
				<div class="move_on_button id:slide_3_b_1_4"></div>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>
		
			<div class="subslide slide_3_b_1_4 i:neulastaClose">
				<h1>Neulasta<sup>&reg;</sup>  reduces FN and related costs<br />by 50% compared to daily G-CSF</h1>
				<h3>Neulasta<sup>&reg;</sup> halves hospitalization cause by to febrile neutropenia</h3>
				<div class="close_button"></div>
				<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
			</div>

		</div>

		<div class="slide slide_4_a i:neulasta4a">
			<h1>Easy to Manage</h1>
			<h2>Easy to Manage</h2>
			<div class="couple"></div>
			<div class="couple_text">
				Neulasta allows me to have the full protection with only one injection per chemotherapy cycle<br /><br />
				No need to return to the clinic multiple times or self administer multiple injections through ideal dosing (with the self regulating mechanism)<br /><br />
				Decreased burden on myself or my family as 1 injection provides optimal protection
			</div>
			<div class="doctor"></div>
			<div class="doctor_text">
				Optimal dosing through self regulating mechanism avoids inadequate dosing  and wasteful dosing<br /><br />
				Optimal protection and support of chemotherapy with one injection per cycle<br /><br />
				Optimal G-CSF support allow for improved chemotherapy delivery and therefore, improved RDI<br /><br />
				Better RDI will lead to better treatment outcomes (including survival)<br /><br />
			</div>
			<div class="nurse"></div>
			<div class="nurse_text">
				No need for multiple injections leaving more time to spend on other responsibilities<br /><br />
				No need to emphasize the importance of continuing the complete number of injections as one shots provides optimal protection<br /><br />
				through decreased incidence of FN and dose delays there is less need to reschedule patients in an already busy CT ward<br /><br />
			</div>
			<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
		</div>

		<div class="slide slide_5_a">
			<h1>Summary calculator</h1>
			<h2>Neulasta&reg; investments</h2>
			<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
		</div>

		<div class="slide slide_6_a i:neulasta6A">
			<h1>Protection of Neulasta<sup>&reg;</sup></h1>
			<h2>Neulasta&reg;</h2>
			<div class="big_match"></div>
			<div class="sectors">
				<div class="anc"></div>
				<div class="anc_arrow"></div>
				<div class="fn"></div>
				<div class="fn_arrow"></div>
				<div class="rdi"></div>
				<div class="rdi_arrow"></div>
				<div class="survival"></div>
			</div>
			<div class="links">
				<div class="anc_link"></div>
				<div class="fn_link"></div>
				<div class="rdi_link"></div>
				<div class="survival_link"></div>
			</div>
			<div class="texts">
				<div class="anc_text">Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.</div>
				<div class="fn_text">Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.</div>
				<div class="rdi_text">Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.</div>
				<div class="survival_text">Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.</div>
			</div>
		</div>

		<div class="slide exit">
			<h1>Exitpage</h1>
		</div>

		<div class="slide slide_7_a i:neulasta7A">
			<div class="study_button"></div>
			<div class="popup"></div>
			<div class="close_study_button"></div>
			<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
		</div>

		<div class="slide slide_8_a i:neulasta8A">
			<h1>Biosimilarity</h1>
			<div class="show_more"></div>
			<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
		</div>

		<div class="slide slide_9_a i:neulasta9A">
			<h1>Non-substitution law<br />- European comparison</h1>
			<div class="countries">
				<div class="sweden">Sweden</div>
			</div>
			<div class="text">
				Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
			</div>
			<div class="reference"><span>- Adapted from Vogel, C. et al.<i>j Clin Oncal. 2005;</i> 23:1178-1184</span></div>
		</div>

		<div class="slide tracks slide_moa">
			
			<div class="track track_moa_1 slide_moa_1 i:moa1">
				<h1>The difference starts at the molecular level</h1>
				<div class="move_on_button id:slide_moa_1_1"></div>
			</div>
	
			<div class="subslide slide_moa_1_1 i:moa11 i:neulastaClose">
				<h1>How does pegylation influence clearance</h1>
				<div class="switch_area id:slide_moa_1_2"></div>
				<div class="close_button"></div>
			</div>
			
			<div class="subslide slide_moa_1_2 i:neulastaClose">
				<h1>How does pegylation influence clearance</h1>
				<div class="i:videos videos">
					<video class="video" controls="controls" poster="img/bg_video_center.jpg"></video>
					<div class="thumb thumb_a src:video/animation_a.mp4"></div>
					<div class="thumb thumb_b src:video/animation_b.mp4"></div>
				</div>
				<div class="close_button"></div>
			</div>
			
		</div>	
		
		<div class="slide slide_moa_2 i:moa2">
			<div class="switch_area"></div>
		</div>
		
		<div class="slide slide_11_a">
			<h1>References</h1>
		</div>
		

	</div>
</div>	
</body>
</html>